Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs NAVITOCLAX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs NAVITOCLAX: Safety Overview

Metric NARATRIPTAN NAVITOCLAX
Total FAERS Reports 526 173
Deaths Reported 9 48
Death Rate 1.7% 27.7%
Hospitalizations 102 119
Average Patient Age 49.2 yrs 40.5 yrs
% Female Patients 90.0% 35.0%
FDA Approval Date Apr 22, 2011 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A